View Older Stories View More Recent Stories

Mar 18, 2026 09:01AM William Blair on Oklo (OKLO): risks to pre-rev biz, but Oklo a leader making progress under reg environment
Mar 18, 2026 08:30AM William Blair on NVIDIA (NVDA): positioned to capture 'lion's share' of AI infra spend 'for years to come'
Mar 17, 2026 05:13PM William Blair on Lantheus Holdings (LNTH) following PDUFA date extended: 'optimistic' co will receive approval
Mar 17, 2026 01:30PM William Blair on Kalaris (KLRS) after positive data: 'blockbuster potential for TH103'
Mar 17, 2026 08:07AM Mastercard deepens stablecoin push with up to $1.8 billion BVNK acquisition
Mar 17, 2026 07:00AM Audax Private Equity Acquires Property Management Company AKAM
Mar 17, 2026 07:00AM Nautic Partners Announces Sale of Property Management Company AKAM
Mar 16, 2026 11:51AM William Blair Reiterates Outperform Rating on Structure Therapeutics (GPCR): 'considerable market opportunity for aleniglipron'
Mar 16, 2026 10:14AM William Blair Reiterates Market Perform Rating on Neogenomics (NEO) following 'much-needed positive catalyst'
Mar 16, 2026 10:09AM William Blair Reiterates Outperform Rating on Dianthus Therapeutics (DNTH): 'should see multiple value inflection for shares'
Mar 16, 2026 07:03AM Alto Neuroscience raises $120 million in private placement financing
Mar 16, 2026 07:03AM Alto Neuroscience Announces $120 Million Private Placement Financing
Mar 16, 2026 06:16AM Street Calls of the Week
Mar 16, 2026 06:02AM William Blair Starts Alamo Group (ALG) at Outperform
Mar 16, 2026 04:34AM European shares snap three-day losing streak as oil prices retreat
Mar 13, 2026 03:45PM William Blair on Fidelity National Info Services (FIS): 'Strong Set of Assets With Compelling Valuation'
Mar 13, 2026 01:12PM William Blair Reiterates Outperform Rating on PAR Technology (PAR) after convertible debt offering announcement
Mar 13, 2026 10:57AM William Blair Reiterates Outperform Rating on Dave Inc (DAVE): 'We recommend investors accumulate DAVE shares'
Mar 13, 2026 10:46AM William Blair: 'The pace at which Carvana is growing puts it in rare air'
Mar 13, 2026 09:32AM Echoes of 2022? Markets look back to Russia play book for Middle East conflict
Mar 13, 2026 09:12AM Ulta Beauty slumps as rising costs hit margins, TikTok push under new CEO in focus
Mar 13, 2026 09:08AM William Blair Reiterates Outperform Rating on ServiceTitan (TTAN): 'we view valuation as attractive'
Mar 13, 2026 08:06AM William Blair Reiterates Market Perform Rating on El Pollo Loco (LOCO) following earnings report
Mar 13, 2026 08:00AM Oxford Lane Capital Corp. Prices Preferred Stock Offering
Mar 13, 2026 07:00AM Leading broker sees 'an attractive risk/reward' in this major AI chip stock
Mar 13, 2026 04:32AM William Blair Downgrades PagerDuty (PD) to Market Perform
Mar 12, 2026 05:04PM William Blair Reiterates Outperform Rating on VSE Corporation (VSEC): "We view today’s 7% stock drawdown as a buying opportunity"
Mar 12, 2026 04:29PM Form N-CEN WILLIAM BLAIR FUNDS For: Dec 31
Mar 12, 2026 04:01PM Xenon Pharmaceuticals closes $747.5 million public offering
Mar 12, 2026 04:01PM Dianthus Therapeutics completes $719 million public offering
Mar 12, 2026 04:01PM Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Mar 12, 2026 04:01PM Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 12, 2026 10:35AM William Blair Reiterates Outperform Rating on Tenaya Therapeutics Inc (TNYA): "entering 2026 with increasing momentum"
Mar 12, 2026 09:17AM William Blair Reiterates Market Perform Rating on UiPath Inc. (PATH): "incrementally encouraged"
Mar 12, 2026 08:45AM William Blair Reiterates Outperform Rating on Aveanna Healthcare Holdings Inc (AVAH) following acquisition announcement
Mar 12, 2026 08:31AM Oxford Lane Capital announces preferred stock offering
Mar 12, 2026 08:30AM Oxford Lane Capital Corp. Announces Preferred Stock Offering
Mar 12, 2026 06:02AM William Blair: 'We like CRCL for long-term investors'
Mar 11, 2026 04:41PM William Blair Reiterates Outperform Rating on AppLovin Corp (APP) following meeting with management
Mar 11, 2026 04:11PM William Blair Reiterates Market Perform Rating on Sprinklr Inc (CXM): "a lot to prove on the execution front"
Mar 11, 2026 05:43AM William Blair: 'increasing likelihood that Oracle sees significant earnings growth acceleration over the coming years'
Mar 10, 2026 10:54PM Dianthus Therapeutics prices $625 million public stock offering
Mar 10, 2026 10:54PM Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering
Mar 10, 2026 10:39PM Xenon Pharmaceuticals prices $650 million stock offering at $57 per share
Mar 10, 2026 10:39PM Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
Mar 10, 2026 02:34PM William Blair Reiterates Outperform Rating on Veeva Systems (VEEV) amid Ostro acquisition
Mar 10, 2026 02:25PM William Blair Reiterates Outperform Rating on Tenax Therapeutics (TENX): "continue to believe positive top-line results from LEVEL have the potential to drive multifold upside"
Mar 10, 2026 02:00PM Medline completes $3.5 billion secondary stock offering
Mar 10, 2026 02:00PM Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares
Mar 10, 2026 12:19PM William Blair Reiterates Outperform Rating on Exagen (XGN) following Q4 results
View More Recent Stories View Older Stories